Nuveen LLC Makes New Investment in MiMedx Group, Inc $MDXG

Key Points

• Nuveen LLC has acquired a new stake of approximately $2.36 million in MiMedx Group, Inc, purchasing 309,878 shares and owning 0.21% of the company as of the most recent SEC filing.
• In the 1st quarter, several large investors increased their holdings in MiMedx Group, with Deutsche Bank AG raising its stake by 144.2%, now owning 321,296 shares valued at about $2.44 million.
• MiMedx Group's stock recently opened at $7.10, with a current market capitalization of $1.05 billion and an average analyst rating of "Buy" with a target price of $12.00.

Nuveen LLC bought a new stake in shares of MiMedx Group, Inc (NASDAQ:MDXG - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 309,878 shares of the company's stock, valued at approximately $2,355,000. Nuveen LLC owned 0.21% of MiMedx Group at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. Paradigm Capital Management Inc. NY lifted its position in shares of MiMedx Group by 0.5% during the fourth quarter. Paradigm Capital Management Inc. NY now owns 4,686,231 shares of the company's stock worth $45,082,000 after purchasing an additional 22,131 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in MiMedx Group by 15.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,802,364 shares of the company's stock worth $17,338,000 after buying an additional 238,075 shares in the last quarter. Northern Trust Corp boosted its position in MiMedx Group by 11.4% in the 4th quarter. Northern Trust Corp now owns 1,199,970 shares of the company's stock valued at $11,544,000 after buying an additional 123,205 shares during the period. Harbor Capital Advisors Inc. grew its stake in shares of MiMedx Group by 4.2% in the first quarter. Harbor Capital Advisors Inc. now owns 1,043,676 shares of the company's stock worth $7,932,000 after acquiring an additional 42,288 shares in the last quarter. Finally, Millennium Management LLC grew its stake in shares of MiMedx Group by 10.1% in the fourth quarter. Millennium Management LLC now owns 634,968 shares of the company's stock worth $6,108,000 after acquiring an additional 58,052 shares in the last quarter. 79.15% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on MDXG shares. Cantor Fitzgerald increased their price objective on MiMedx Group from $11.00 to $12.00 and gave the company an "overweight" rating in a research note on Thursday, July 31st. Wall Street Zen upgraded MiMedx Group from a "hold" rating to a "strong-buy" rating in a report on Saturday, August 2nd. One investment analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average price target of $12.00.

MiMedx Group Stock Down 0.1%

Shares of MiMedx Group stock traded down $0.01 during trading hours on Thursday, hitting $7.09. The company had a trading volume of 353,303 shares, compared to its average volume of 472,979. The company has a debt-to-equity ratio of 0.08, a current ratio of 4.39 and a quick ratio of 3.90. The company's 50-day moving average is $6.87 and its two-hundred day moving average is $7.01. The company has a market cap of $1.05 billion, a P/E ratio of 33.76 and a beta of 1.74. MiMedx Group, Inc has a twelve month low of $5.47 and a twelve month high of $10.14.

MiMedx Group (NASDAQ:MDXG - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.06 by $0.04. MiMedx Group had a net margin of 8.84% and a return on equity of 23.03%. The firm had revenue of $98.61 million for the quarter, compared to analyst estimates of $90.79 million. Analysts anticipate that MiMedx Group, Inc will post 0.3 earnings per share for the current fiscal year.

MiMedx Group Profile

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins.